Editors' ChoiceCancer

PARP inhibitors need an extra STING for therapeutic efficacy

See allHide authors and affiliations

Science Translational Medicine  29 May 2019:
Vol. 11, Issue 494, eaax9557
DOI: 10.1126/scitranslmed.aax9557

Article Information

vol. 11 no. 494

Print ISSN: 
Online ISSN: 
  • .

Author Information

  1. Anand D. Jeyasekharan
  1. Department of Haematology-Oncology, National University Hospital and Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. Email: csiadj{at}nus.edu.sg


Article usage

Article usage: May 2019 to October 2019

May 201910920509
Jun 2019131177214
Jul 2019143001
Aug 2019112066
Sep 201962022
Oct 20194826

Navigate This Article